# Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial

> **NCT05356117** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 45 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BEHAVIORAL:** Resistance Training (RT) and Protein Supplementation (PS)
- **BEHAVIORAL:** Resistance Training (RT)
- **BEHAVIORAL:** Attention Control (AC

## Key facts

- **NCT ID:** NCT05356117
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-01
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-08-15
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05356117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05356117, "Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05356117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*